These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 2577255)

  • 1. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Sohn I
    Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of thyrotropin-induced growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema.
    Iida Y; Konishi J; Kasagi K; Misaki T; Arai K; Tokuda Y; Torizuka K
    J Clin Endocrinol Metab; 1987 Jan; 64(1):124-30. PubMed ID: 3023425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins.
    Takasu N; Yamada T; Katakura M; Yamauchi K; Shimizu Y; Ishizuki Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):239-45. PubMed ID: 2878935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient neonatal hypothyroidism due to transplacental transfer of maternal immunoglobulins that inhibit TSH binding, TSH-induced cAMP increase and cell growth.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Lee M
    Endocrinol Jpn; 1988 Dec; 35(6):819-26. PubMed ID: 2907987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
    Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
    Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
    Akamizu T; Kohn LD; Hiratani H; Saijo M; Tahara K; Nakao K
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thyrotropin-induced adenosine 3'5'-monophosphate increase by immunoglobulins from patients with primary myxedema.
    Konishi J; Iida Y; Endo K; Misaki T; Nohara Y; Matsuura N; Mori T; Torizuka K
    J Clin Endocrinol Metab; 1983 Sep; 57(3):544-9. PubMed ID: 6135705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis.
    Tamaki H; Amino N; Aozasa M; Mori M; Iwatani Y; Tachi J; Nose O; Tanizawa O; Miyai K
    Am J Perinatol; 1989 Jul; 6(3):296-303. PubMed ID: 2567172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence and little change in TSH receptor blocking antibody titres with thyroxine and antithyroid drug therapy in patients with non-goitrous autoimmune thyroiditis.
    Cho BY; Kim WB; Chung JH; Yi KH; Shong YK; Lee HK; Koh CS
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):465-71. PubMed ID: 7586622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis.
    Kraiem Z; Lahat N; Glaser B; Baron E; Sadeh O; Sheinfeld M
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):409-21. PubMed ID: 2830061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goitrous hypothyroidism with blocking or stimulating thyrotropin binding inhibitor immunoglobulins.
    Sato K; Okamura K; Yoshinari M; Ikenoue H; Kuroda T; Torisu M; Fujishima M
    J Clin Endocrinol Metab; 1990 Oct; 71(4):855-60. PubMed ID: 1976127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan.
    Tamaki H; Amino N; Kimura M; Hidaka Y; Takeoka K; Miyai K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1382-6. PubMed ID: 1977757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y; Hamazu M; Kajita Y; Nagata A
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of L-thyroxine therapy.
    Khoo DH; Eng PH; Ho SC; Fok AC
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):73-9. PubMed ID: 10468968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between potency of blocking type thyrotropin-binding inhibitor immunoglobulin in three women with primary myxedema and thyroid function of their neonates.
    Inomata H; Sasaki N; Tamaru K; Ushiku H; Niimi H; Nakajima H
    Endocrinol Jpn; 1986 Jun; 33(3):353-9. PubMed ID: 3019652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenetic role of thyrotropin receptor antibody in the development of hyperthyroidism following primary hypothyroidism.
    Shong YK; Cho BY; Hong SK; Lee HK; Koh CS; Min HK
    Korean J Intern Med; 1989 Jul; 4(2):118-24. PubMed ID: 2577256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.